CSIMarket
 


Akers Biosciences Inc   (AKER)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Akers Biosciences Inc 's Leverage Ratio

AKER's quarterly Leverage Ratio and Total Liabilities, Equity growth




AKER Leverage Ratio (Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
Y / Y Equity Change 488.33 % 270.23 % 37.28 % 60.36 % -53.39 %
Y / Y Total Liabilities Change 83.19 % 62.3 % 10.98 % -22.48 % -40.34 %
Leverage Ratio MRQ 0.12 0.16 0.34 0.16 0.38
Overall Ranking # # # # #
Seq. Equity Change 32.54 % 134.28 % -27.13 % 160 % -16.6 %
Seq. Total Liabilities Change -4.21 % 13.94 % 50.63 % 11.42 % -15.13 %



Leverage Ratio third quarter 2020 Comment
Due to repayements of liabilities of -4.21% Akers Biosciences Inc improved Leverage Ratio in third quarter 2020 to 0.12, below company's average Leverage Ratio.

Within Biotechnology & Drugs industry in the third quarter 2020, 46 other companies have achieved lower Leverage Ratio than Akers Biosciences Inc . While total ranking remained unchanged compare to previous quarter at no. .

Explain Leverage Ratio?
Who are AKER Customers?
Leverage Ratio third quarter 2020 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 47
Healthcare Sector # 129
Overall Market # 259


Leverage Ratio Statistics
High Average Low
0.5 0.24 0.07
(Dec 31 2016)   (Jun 30 2014)




Financial Statements
Akers Biosciences Inc 's Equity $ 21 Millions Visit AKER's Balance sheet
Akers Biosciences Inc 's Total Liabilities $ 3 Millions Visit AKER's Balance sheet
Source of AKER's Sales Visit AKER's Sales by Geography




Companies with similar Leverage Ratio in the quarter endingSep 30 2020, within Biotechnology & Drugs Industry Leverage RatioSep 30 2020 MRQ Total LiabilitiesSep 30 2020 MRQ Equity
Fulgent Genetics Inc   0.32 $ 60.356  Millions$ 186.955  Millions
Zymeworks Inc   0.32 $ 139.365  Millions$ 432.354  Millions
Repligen Corp  0.31 $ 346.986  Millions$ 1,124.870  Millions
G1 Therapeutics Inc   0.31 $ 60.760  Millions$ 197.472  Millions
Regenxbio Inc   0.30 $ 125.514  Millions$ 415.660  Millions
Citius Pharmaceuticals Inc   0.30 $ 10.103  Millions$ 33.671  Millions
Atyr Pharma Inc  0.30 $ 9.475  Millions$ 31.998  Millions
Jounce Therapeutics Inc   0.29 $ 30.746  Millions$ 105.087  Millions
Scpharmaceuticals Inc   0.29 $ 26.097  Millions$ 89.815  Millions
Cohbar Inc   0.29 $ 5.458  Millions$ 19.038  Millions
Protagonist Therapeutics inc   0.28 $ 47.730  Millions$ 169.590  Millions
Eidos Therapeutics Inc   0.28 $ 34.358  Millions$ 122.856  Millions
Orgenesis Inc   0.28 $ 24.092  Millions$ 86.808  Millions
Bluebird Bio Inc   0.28 $ 422.463  Millions$ 1,523.021  Millions
Adaptimmune Therapeutics Plc  0.27 $ 102.816  Millions$ 376.206  Millions
Anavex Life Sciences Corp   0.27 $ 7.306  Millions$ 27.237  Millions
Quanterix Corp  0.26 $ 55.064  Millions$ 209.041  Millions
Highwater Ethanol Llc  0.26 $ 3.312  Millions$ 12.581  Millions
Cannabics Pharmaceuticals Inc   0.26 $ 0.455  Millions$ 1.765  Millions
Procyon Corp  0.24 $ 0.583  Millions$ 2.383  Millions
Cure Pharmaceutical Holding Corp   0.24 $ 6.014  Millions$ 24.624  Millions
Casi Pharmaceuticals Inc   0.23 $ 21.440  Millions$ 91.527  Millions
Myokardia Inc   0.23 $ 190.683  Millions$ 844.978  Millions
Cue Biopharma Inc   0.22 $ 19.064  Millions$ 87.553  Millions
Nantkwest Inc   0.21 $ 31.913  Millions$ 148.622  Millions
Denali Therapeutics Inc   0.21 $ 187.756  Millions$ 882.550  Millions
Pdl Biopharma Inc   0.21 $ 124.006  Millions$ 593.278  Millions
Sun Biopharma Inc   0.20 $ 1.936  Millions$ 9.549  Millions
Berkeley Lights Inc   0.20 $ 49.427  Millions$ 250.583  Millions
Lixte Biotechnology Holdings Inc   0.19 $ 0.222  Millions$ 1.141  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

PLCE's Profile

Stock Price

PLCE's Financials

Business Description

Fundamentals

Charts & Quotes

PLCE's News

Suppliers

PLCE's Competitors

Customers & Markets

Economic Indicators

PLCE's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071